Here are relevant reports on : virtual-human-market
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Choline Chloride Market by End-User (Poultry feed, Swine feed, Ruminant feed, Aqua feed & others, Human nutrition and Oil & Gas, and Misc. applications), and Geography - Regional Trends & Forecast to 2019
Choline chloride is an organic compound. It is used in the animal feed additive. It is mainly related with the metabolism and act as methyl donor. It builds and maintains cell structure and function. It is very essential for growing animal and its feed intake helps in preventing perosis, conditions like fatty liver syndrome, etc. Apart from animal feed additive, it is also used in human nutrition and as a clay stabilizer in oil and gas industry.
- Published: April 2014
- Price: $ 4950
- TOC Available:
-
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)
The global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Swarm Intelligence Market by Model, Capability (Clustering, Routing, Scheduling, and Optimization), Application (Robotics, Drones, and Human Swarming), and Geography - Global Forecast to 2030
The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The estimated year considered for the study is 2020, and the forecast period is between 2020 and 2023. The report profiles the most promising players in this market. The key players in this market are DoBots (Netherlands), Hydromea (Switzerland), Sentien Robotics (US), Unanimous A.I. (US), AxonAI (US), Swarm Technology (US), SSI Schäfer - Fritz Schäfer (Germany), Valutico (Austria), Enswarm (UK), and Power-Blox (Switzerland).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Task Management Software Market by Business Function (Marketing, Human Resource, Finance), Component (Software and Services), Deployment Type (Cloud and On-Premises), Organization Size, Industry Vertical, and Region - Global Forecast to 2023
The global task management software market size is expected to grow from USD 2.27 billion in 2018 to USD 4.33 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 13.7% during the forecast period. The major factors driving the market growth include the digital transformation initiatives that have led to improved IT systems to meet customers’ dynamic requirements. The major industry verticals in the market include Banking, Financial Services, and Insurance (BFSI); retail and consumer goods; and Information Technology (IT) and telecom; and real estate and construction. The major vendors offering task management software and services across the globe include Microsoft (US), Upland Software (US), Atlassian (Australia), Pivotal Software (US), RingCentral (US), Azendoo (France), Asana (US), Bitrix (US), Doist (Spain), monday.com (Israel), Quick Base (US), Redbooth (US), todo.vu (Australia), Teamwork.com (Ireland), Workfront (US), Wrike (US), Zoho (US), Airtable (US), Basecamp (US), Clarizen (US), Evernote Corporation (US), Inflectra (US), MeisterLabs (Austria), Smartsheet (US), and TimeCamp (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Human Centric Lighting Market by Offering (Hardware (Lighting fixtures and Lighting Controllers), Software, and Services), Installation Type (New Installations and Retrofit Installations), Application, and Geography - Global Forecast to 2036
The human centric lighting market was valued at USD 3.66 billion in 2024 and is projected to reach USD 25.25 billion by 2036, growing at a CAGR of 17.1% from 2025 to 2036 The growth of the human centric lighting market is driven by the high adoption of LED lighting solutions; initiatives toward establishing smart cities; and the rising in demand for energy-efficient lighting solutions. The implementation of wireless technology for LED lighting is expected to provide huge growth opportunities to market players. The human centric lighting market is currently dominated by Signify Lighting NV (Netherlands), OSRAM Licht AG (Germany), Acuity Brands, Inc. (US), Cree, Inc. (US), Legrand SA (France), Hubbell Inc. (US), Zumtobel Group AG (Austria), Wipro Enterprises (P) Ltd. (India), Glamox AS (Norway), and Lutron Electronics Co., Inc. (US). A few of the major strategies adopted by these players to compete in the human centric lighting market include product launches and developments, partnerships, and mergers and acquisitions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Eye Tracking Market by Offering (Hardware, Software, Services), Tracking Type (Remote and Mobile), Application (Assistive Communication, and Human Behavior & Market Research), Vertical, and Geography- Global Forecast to 2025
The Eye Tracking Market is expected to grow from USD 368 million in 2020 to USD 1,098 million by 2025, at a CAGR of 24.5% during the forecast period. A few key players operating in the eye tracking market are Tobii (Sweden), EyeTracking (US), SR Research (Canada), Seeing Machines (Australia), PRS IN VIVO (France), Smart Eye (Sweden), EyeTech Digital Systems (US), Eyegaze (US), Ergoneers (Germany), ISCAN (US), iMotions (Denmark), and Lumen Research (UK).
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
Vaccine Adjuvants Market by Product (Emulsions, Pathogen, Saponin, Particulate), ROA (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Vaccine (Human, Veterinary (Companion, Livestock)), Type (Organic, Inorganic) - Global Forecast to 2029
The global vaccine adjuvants market, valued at US$0.66 billion in 2023, stood at US$0.70 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$0.96 billion by the end of the period. Growing awareness about livestock health, increasing the adoption of companion animals and developing of therapeutic vaccines for cancer, allergies, and autoimmune disorders are creating lucrative growth opportunities
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
